ML-1 - PDFSEARCH.IO - Document Search Engine

ML-1
Results: 854

#	Item
581	NOTICE OF PUBLIC HEARING INSURANCE COMMISSIONER KAREN WELDIN STEWART, CIR-ML, hereby gives notice that a PUBLIC HEARING (the “Hearing”) will be held on Friday, December 5, 2014 at 10:30 a.m. prevailing Eastern time Add to Reading List Source URL: delawareinsurance.gov Language: English - Date: 2014-11-10 12:09:20 Silver Lake Delaware Route 1 Insurance commissioner Delaware Geography of the United States Karen Weldin Stewart
582	REVISED 1 NOTICE OF PUBLIC HEARING INSURANCE COMMISSIONER KAREN WELDIN STEWART, CIR-ML, hereby gives notice that a PUBLIC HEARING will be held on Monday, December 29, 2014 at 10:30 a.m. prevailing Eastern time at the law Add to Reading List Source URL: www.delawareinsurance.gov Language: English - Date: 2014-12-08 16:16:47 Delaware Geography of the United States United States Karen Weldin Stewart Wilmington Delaware Insurance commissioner
583	NOTICE OF PUBLIC HEARING INSURANCE COMMISSIONER KAREN WELDIN STEWART, CIR-ML, hereby gives notice that a PUBLIC HEARING (the “Hearing”) will be held on Friday, December 5, 2014 at 10:30 a.m. prevailing Eastern time Add to Reading List Source URL: www.delawareinsurance.gov Language: English - Date: 2014-11-10 12:09:20 Silver Lake Delaware Route 1 Insurance commissioner Delaware Geography of the United States Karen Weldin Stewart
584	C CH 2 CH 2 CH2 N O CI Haloperidol Injection, USP is available as a sterile parenteral form for intramuscular injection in a 1 mL single-dose vial, each mL containing 5 mg haloperidol (as the lactate) and lactic acid for Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2013-10-30 14:55:39 Medicine Organochlorides Syndromes Organofluorides Alcohols Haloperidol Antipsychotic Typical antipsychotic Tardive dyskinesia Chemistry Organic chemistry Antiemetics
585	Metacam oral suspension 1.5 mg/mL Add to Reading List Source URL: www.fda.gov Language: English Organic chemistry Dog health Meloxicam Carprofen Deracoxib Aspirin COX-2 inhibitor Ibuprofen Etodolac Non-steroidal anti-inflammatory drugs Chemistry Veterinary medicine
586	FDA Tentative Approval[removed]Abacavir Sulfate Oral Solution (20 mg/mL) Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-10-16 03:51:12 Cyclopropanes Pharmacology Health Medicine GlaxoSmithKline Organofluorides Lamivudine Antiretroviral drug Reverse-transcriptase inhibitor Purines Fixed dose combination Abacavir
587	FDA Tentative Approval[removed]; Approval March 8, 2007 Didanosine for Oral Solution (Pediatric Powder), 10 mg/mL Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-12-08 04:14:12 Purines Piperazines HIV/AIDS Bristol-Myers Squibb Didanosine Zalcitabine Protease inhibitors Tenofovir Ribavirin Chemistry Organic chemistry Medicine
588	FDA Tentative Approval November 8, 2005 Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-12-08 04:25:30 Organic chemistry Cyclopropanes Antiretroviral drug Reverse-transcriptase inhibitor Fixed dose combination Purines Non-nucleoside reverse transcriptase inhibitors Abacavir Organofluorides Chemistry Lamivudine
589	FDA Approval March 20, 2009 Stavudine Powder for Oral Solution USP, 1 mg/mL Cipla Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2010-06-28 08:13:34 Stavudine Pharmacology Cipla Antiretroviral drug Adverse effect Reverse-transcriptase inhibitor Bristol-Myers Squibb Medicine Health
590	USFDA Approval September 19, 2005 Zidovudine Syrup (Zidovudine Oral Solution) 50 mg/5 mL Aurobindo Pharma, Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-12-08 04:25:30 Bristol-Myers Squibb Organofluorides Azides Zidovudine Antiretroviral drug Cyclopropanes Stavudine Ribavirin Flucytosine Chemistry Pharmacology Medicine

UPDATE